TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| TG THERAP (NASDAQ: TGTX) | Delayed: 53.10 -0.1 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.20 | 52 Week High | $14.87 | |||
| Open | $53.02 | 52 Week Low | $4.90 | |||
| Day High | $53.70 | P/E | N/A | |||
| Day Low | $52.53 | EPS | $-0.67 | |||
| Volume | 632,788 | |||||
